According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

In a significant drug bust, the Boisar MIDC police successfully raided a building in the Katkar Pada area of Boisar and ...

The early morning operation targets multiple properties in Dover, Deal, Thanet and Aylesham. A report says the existing facility in Hartlepool's Whitby Street is in a deteriorating condition ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Large-scale ...

Mumbai: Maharashtra Administrative Tribunal (MAT) held BAMS graduates eligible to be appointed for officers' posts in Food and Drug Administration (FDA). Almost 40 BAMS graduates were deemed ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

On the first day of the World Economic Forum in Davos, Maharashtra signed memorandums of understanding (MoUs) worth ₹4.99 lakh crore. These investments are expected to generate 92,235 jobs.

Maharashtra, on the first day of the World Economic Forum (WEF) in Davos, has signed a memorandum of understanding (MoU) worth over Rs 4.99 lakh crore. This substantial investment promises to ...

Apart from the delegation from these States, the second one has pavilions of Andhra Pradesh, Maharashtra and Tamil Nadu. Both pavilions will also host five Union ministers at different times.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...